Tagged Articles

lung cancer 35 articles

Alabama woman files asbestos lawsuit against several manufacturers

Alabama resident Shirley Sanders, on behalf of the estate of her late husband Mac Arthur Sanders, filed a lawsuit against nearly two dozen manufacturers in St. Clair County Circuit Court in Illinois, alleging products manufactured by the companies contained cancer causing asbestos and contributed to her husband’s lung cancer diagnosis. The lawsuit names, in part, Air & Liquid Systems Corporation, Goulds Pumps Inc., and Lamons Gasket Company, companies that manufactured products Mac Arthur Sanders worked with. Shirley Sanders claims that microscopic asbestos fibers emanated from some of the products manufactured by the companies. Those airborne fibers were inhaled or ingested ... Read More

National Radon Action Month highlights the importance of home testing

It has no taste, no smell and no discernible way to be detected by the human eye. It is the No. 2 cause of lung cancer in America, and it is a gas we breathe every day. Radon gas is produced from a natural breakdown of uranium in soil, rock and water, and is deadly when a person is exposed to high levels, according to the National Safety Council. The council advises testing for the risk of radon gas exposure during January, National Radon Action Month. Scientists estimate 15,000 to 22,000 lung cancer deaths each year in the U.S. are ... Read More

FDA cannot guarantee baby powders, body powders do not contain asbestos

Pathologists, cancer specialists and experts in lawsuits have warned that products like baby powders and body powders containing talcum powder can cause deadly mesothelioma and ovarian cancer, but the Food and Drug Administration (FDA) says it has no legal grounds to protect consumers from these products. Talcum is derived from talc, a natural mineral composed of other minerals such as asbestos, a known carcinogen which has been linked to the deadly form of lung cancer, mesothelioma. Talcum powder is found in cosmetics and body and baby powders. It also has been used in the manufacturing of tires, paper, thermoplastics, polymers, paints, and ... Read More

Researchers raise safety concerns about nanoparticles in sunscreens, baby power

Nanoparticles, or the tiny bits of particles produced when a mineral is broken down into smaller and smaller bits, have been present for years in consumer products from baby powder to sunscreens, however they may ultimately do more harm than good. For an example, chemistry professor Jerry Harris with Northwest Nazarene University refers to asbestos, a mineral that became widely used in the United States in the 20th century as insulation because it was affordable and was efficient at absorbing sound when milled down. However, decades later it was discovered that inhaling nanoparticles of asbestos could cause lung cancer, mesothelioma, ... Read More

Researchers aim to understand the potential harm in nanoparticles

When a mineral is broken down into smaller and smaller particles, or nanoparticles, its biological makeup can be affected, turning a seemingly harmless mineral into a potential lethal threat. Understanding which minerals’ nanoparticles pose risks is the work of a group of researchers at Northwest Nazarene University. Chemistry professor Jerry Harris refers to the book, “Asbestos: Silk of the Mineral Kingdom,” which was published in 1946 and touted the benefits of abestos. Asbestos became widely used in the United States throughout the 20th century as insulation because of its affordability and sound absorption. What researchers didn’t learn until decades later ... Read More

Low dose aspirin therapy may help prevent pancreatic cancer

A low, daily dose of aspirin has been praised for its cardiovascular benefits, but new research shows that the therapy may also ward off pancreatic cancer, one of the deadliest forms of the disease. The study, conducted by researchers at the Yale School of Public Health, claims daily low-dose aspirin therapy can lower pancreatic cancer risk by up to 48 percent. Low-dose aspirn therapy has already been credited for reducing risk of ovarian, colorectal, stomach, esophageal, prostate, breast, lung, and skin cancers. Researchers studied information on aspirin use and medical histories for 362 people with pancreatic cancer and 690 people ... Read More

Many breast cancer patients don’t seek prompt treatment for drug-related heart failure

About 12 percent of breast cancer patients treated with chemotherapy drugs develop heart failure within three years after cancer treatment, but only a third saw a cardiologist within 90 days of the onset of symptoms, according to a new study. The research was presented at the American Cancer Society meeting in Baltimore. The study involved data from about 8,400 breast cancer patients age 65 and older who were treated either with chemotherapy drugs called anthracyclines, or a targeted therapy trastuzumab. Both drugs have been previously linked to heart problems. Researchers said that patients who saw a cardiologist were more likely ... Read More

Experimental new drug shows promise in treatment of advanced melanoma

Warwick Steele, 64, was given just months to live when he was diagnosed with melanoma, the deadliest form of skin cancer. With few treatment options, many of which had less-than-promising results, Steele volunteered to enroll in a clinical trial for a radical new treatment called pembrolizumab. Three months later, a date doctors doubted Steele would ever see, the man was tumor free and the cancer showed no signs of returning. “We cannot say for certain that he’s been cured, but he is doing very well,” says Dr. David Chao with the Royal Free Hampstead NHS in London, who serves as ... Read More

FDA delays decision on diabetes inhaler to review possible cancer risks

The Food and Drug Administration (FDA) has delayed its decision about whether to approve Mannkind Corp.’s Afrezza, an inhaled insulin treatment for diabetes, due to concerns about an increased risk of lung cancer. The delay comes just one week after an advisory panel recommended the approval of the therapy for both type 1 and type 2 diabetes under the condition that the drug company collect long-term data on cancer risks and other potential side effects. Afrezza is a whistle-sized device designed to deliver a fast-acting dose of insulin. It offers a convenient alternative for many diabetic patients who currently have to ... Read More

FDA panel recommends approval of novel inhaled diabetes treatment

An advisory committee for the Food and Drug Administration (FDA) is recommending marketing approval for a novel inhaled drug to treat both type 1 and type 2 diabetes. Afrezza, manufactured by MannKind Corp., is a whistle-sized device that is designed to deliver a more effective, fast acting dose of insulin. The product offers a crucial alternative for many diabetics who currently have to undergo regular injections, which can be both painful and cumbersome. If approved, Afrezza would be the first inhaled insulin therapy in the United States since 2006, when Pfizer introduced Exubera, an inhaler that was discontinued due to ... Read More